SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000812796-08-000028
Filing Date
2008-05-16
Accepted
2008-05-16 07:24:04
Documents
2
Period of Report
2008-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 DOR 8K FOR EARNINGS RELEASE 1Q 2008 earnings8kfor1q2008.htm 8-K 22615
2 DOR PRESS RELEASE 1Q2008 presselease1q2008.htm EX-99.1 20586
  Complete submission text file 0000812796-08-000028.txt   44925
Mailing Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628
Business Address 850 BEAR TAVERN ROAD SUITE 201 EWING NJ 08628 609-538-8200
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16929 | Film No.: 08840330
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1